Qiming U.S. Ventures Management as of Dec. 31, 2021
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Icosavax | 37.0 | $80M | 3.5M | 22.88 | |
| Jasper Therapeutics | 21.1 | $46M | 5.9M | 7.85 | |
| Talaris Therapeutics | 20.6 | $45M | 2.9M | 15.29 | |
| Ventyx Biosciences (VTYX) | 8.3 | $18M | 910k | 19.86 | |
| Elevation Oncology (ELEV) | 6.6 | $14M | 2.4M | 6.02 | |
| Kezar Life Sciences (KZR) | 6.4 | $14M | 829k | 16.72 |
